Peter Bader Selected Research

Pathologic Complete Response

1/2021	Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study.
1/2019	Methods and role of minimal residual disease after stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Bader Research Topics

Disease

47	Neoplasms (Cancer) 11/2021 - 11/2002
38	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 02/2003
29	Leukemia 01/2022 - 02/2003
25	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 05/2003
14	Residual Neoplasm 01/2022 - 01/2009
10	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2004
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 11/2004
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 11/2011
8	Infections 12/2021 - 03/2015
6	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 01/2005
5	Juvenile Myelomonocytic Leukemia 10/2020 - 02/2003
4	Disease Progression 03/2022 - 07/2008
4	Rhabdomyosarcoma 03/2021 - 09/2010
4	Cytopenia 01/2020 - 03/2005
4	Multiple Myeloma 01/2018 - 05/2003
3	Cytokine Release Syndrome 01/2022 - 01/2018
3	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2021 - 01/2018
3	Osteonecrosis (Kienbock's Disease) 12/2020 - 10/2018
3	Communicable Diseases (Infectious Diseases) 06/2020 - 01/2020
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 12/2017
3	Bronchiolitis Obliterans Syndrome 01/2020 - 01/2018
3	Virus Diseases (Viral Diseases) 01/2019 - 03/2015
3	Neuroblastoma 01/2019 - 02/2010
3	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2012
3	Sepsis (Septicemia) 12/2016 - 02/2015
3	Ewing Sarcoma (Sarcoma, Ewing) 10/2016 - 01/2005
3	Lymphoma (Lymphomas) 01/2015 - 11/2004
2	Inflammation (Inflammations) 03/2022 - 09/2011
2	Leukocyte adhesion deficiency type 1 03/2022 - 12/2021
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022 - 02/2003
2	Immune System Diseases (Immune Disorders) 01/2022 - 10/2019
2	Primary Immunodeficiency Diseases 12/2021 - 01/2018
2	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2021 - 01/2020
2	Pathologic Complete Response 01/2021 - 01/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2018
2	Iron Overload 01/2020 - 12/2018
2	Hematologic Diseases (Blood Diseases) 01/2020 - 01/2020
2	Sickle Cell Anemia (Hemoglobin S Disease) 12/2019 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 11/2002
2	Bacterial Infections (Bacterial Infection) 05/2015 - 02/2015
2	Viremia 03/2015 - 02/2015
2	Aspergillosis 06/2008 - 05/2006
2	Carcinoma (Carcinomatosis) 03/2005 - 06/2004
1	Reinfection 03/2022
1	COVID-19 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Alveolar Rhabdomyosarcoma 01/2022
1	Hemorrhage 12/2021

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 03/2021 - 01/2004
11	Chimeric Antigen ReceptorsIBA 01/2022 - 10/2016
6	blinatumomabIBA 01/2022 - 12/2016
5	AntigensIBA 01/2021 - 08/2013
4	tisagenlecleucelIBA 01/2022 - 01/2018
4	LigandsIBA 11/2010 - 01/2004
3	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 11/2002
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 05/2003
3	SteroidsIBA 01/2018 - 08/2011
3	Interleukin-2 (IL2)IBA 09/2011 - 02/2010
3	Cytostatic AgentsIBA 03/2006 - 11/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
2	VaccinesIBA 01/2022 - 08/2013
2	Ferritins (Ferritin)IBA 08/2021 - 12/2018
2	Busulfan (Busulfex)FDA Link 01/2021 - 01/2017
2	treosulfanIBA 01/2021 - 10/2020
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2021 - 10/2020
2	fludarabineIBA 01/2021 - 10/2020
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 05/2003
2	Carrier Proteins (Binding Protein)IBA 11/2019 - 09/2010
2	Biological ProductsIBA 11/2019 - 12/2016
2	interleukin-21 (interleukin 21)IBA 01/2019 - 01/2017
2	Interleukin-15 (Interleukin 15)IBA 01/2019 - 01/2012
2	AntibodiesIBA 01/2018 - 05/2004
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2015
2	InterleukinsIBA 01/2017 - 01/2012
2	HLA Antigens (Human Leukocyte Antigens)IBA 05/2015 - 02/2015
2	Antiviral Agents (Antivirals)IBA 03/2015 - 03/2015
2	Interferon-gamma (Interferon, gamma)IBA 11/2011 - 02/2010
2	Vorinostat FDA Link 03/2006 - 03/2005
2	Histone Deacetylase InhibitorsIBA 03/2006 - 03/2005
2	Antineoplastic Agents (Antineoplastics)IBA 03/2006 - 11/2002
2	trichostatin A (A 300)IBA 03/2006 - 03/2005
2	Butyric Acid (Butanoic Acid)IBA 03/2006 - 03/2005
2	IsoenzymesIBA 06/2004 - 11/2002
2	Protein Kinase CIBA 06/2004 - 11/2002
2	Vincristine (Oncovin)FDA LinkGeneric 06/2004 - 11/2002
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 03/2022
1	IntegrinsIBA 03/2022
1	Immunoglobulin A (IgA)IBA 11/2021

Therapy/Procedure

57	Hematopoietic Stem Cell Transplantation 03/2022 - 01/2005
51	Stem Cell Transplantation 01/2021 - 05/2003
41	Transplantation 01/2022 - 02/2003
37	Therapeutics 01/2022 - 05/2004
13	Immunotherapy 03/2021 - 05/2004
7	Drug Therapy (Chemotherapy) 01/2021 - 05/2006
5	Cell Transplantation 01/2022 - 12/2015
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2015 - 01/2004
3	Homologous Transplantation 04/2015 - 01/2009
3	Haploidentical Transplantation 06/2014 - 09/2004
2	Consolidation Chemotherapy 10/2016 - 11/2005